As Market Access and Health Economics & Outcomes Research Lead, I work at the intersection of evidence generation, access strategy, and commercialization, securing and sustaining patient access to SkylineDx innovations across diverse healthcare markets.

As a health economist, I believe that rigorous scientific evidence, paired with strategic thinking, is the most powerful tool for demonstrating the value of novel diagnostics to the healthcare systems and decision-makers that shape patient access. My work ensures that groundbreaking science translates into real-world impact for patients with significant unmet needs.

At SkylineDx, I am fortunate to combine intellectual challenge with meaningful purpose, contributing to a company where cutting-edge science and patient-centered innovation go hand in hand.